Journal Logo

Poster Session II: Myeloma and other monoclonal gammopathies – Clinica

PS1392 CONSOLIDATION WITH A SHORT COURSE OF DARATUMUMAB CAN SIGNIFICANTLY IMPROVE COMPLETE RESPONSE RATES IN PATIENTS WITH AL AMYLOIDOSIS OR LCDD

Kastritis, E.1; Gavriatopoulou, M.1; Kostopoulos, I.V.2; Dialoupi, I.1; Roussou, M.1; Kanellias, N.1; Fotiou, D.1; Eleutherakis-Papaiakovou, E.1; Ntanasis-Stathopoulos, I.1; Migkou, M.1; Ziogas, D.C.1; Papanota, A.-M.1; Papanikolaou, A.3; Gakiopoulou, C.4; Psimenou, E.1; Tselegkidi, M.E.1; Tsitsilonis, O.2; Trougakos, I.2; Terpos, E.1; Dimopoulos, M.A.1

Author Information
doi: 10.1097/01.HS9.0000563844.56755.35
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.